aspirin has been researched along with pyrazinamide in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (48.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 4 (16.00) | 29.6817 |
2010's | 8 (32.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Boss, GR; Seegmiller, JE | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
Allan, WG; Fox, W; Girling, DJ; Horsfall, PA; Nunn, AJ; Plummer, J | 1 |
Fox, IH; Sinclair, DS | 2 |
Fox, IH; Hasan, A; Stein, HB | 1 |
Hirata, Y; Itoh, H; Iwamoto, H; Marumo, F; Shichiri, M | 1 |
Johnston, RF; Wildrick, KH | 1 |
Fox, IH; Gershon, SL | 1 |
Diamond, HS; Paolino, JS | 1 |
Diamond, HS; Sharon, E | 1 |
Ardaillou, R; Fontanelle, J; Hornych, A; Paillard, F; Podevin, R; Richet, G | 1 |
DALRYMPLE, GV; PETTY, TL | 1 |
Byrne, ST; Denkin, SM; Zhang, Y | 1 |
Bhoi, SK; Kalita, J; Misra, UK; Prasad, S | 1 |
4 review(s) available for aspirin and pyrazinamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hyperuricemia and gout. Classification, complications and management.
Topics: Acute Disease; Allopurinol; Arthritis; Aspirin; Colchicine; Coronary Disease; Diuretics; Gout; Humans; Hypoxanthine Phosphoribosyltransferase; Indomethacin; Kidney; Kidney Calculi; Kidney Diseases; Lead Poisoning; Lymphoproliferative Disorders; Myeloproliferative Disorders; Phenylbutazone; Platelet Aggregation; Probenecid; Purine-Pyrimidine Metabolism, Inborn Errors; Pyrazinamide; Ribose-Phosphate Pyrophosphokinase; Uric Acid; Uricosuric Agents | 1979 |
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
Topics: Aspirin; Benzbromarone; Benzofurans; Drug Interactions; Fasting; Gout; Humans; Kidney Diseases; Kinetics; Lipid Metabolism; Pyrazinamide; Triglycerides; Uric Acid; Xanthine Oxidase | 1977 |
The impact of chemotherapy on the care of patients with tuberculosis.
Topics: Antitubercular Agents; Aspirin; Bacteriological Techniques; BCG Vaccine; Drug Therapy, Combination; Ethambutol; Hospitalization; Humans; Isoniazid; Length of Stay; Mycobacterium tuberculosis; Outpatient Clinics, Hospital; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculin Test; Tuberculosis, Pulmonary | 1974 |
2 trial(s) available for aspirin and pyrazinamide
Article | Year |
---|---|
Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration.
Topics: Adolescent; Adult; Aged; Allopurinol; Aspirin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Joint Diseases; Male; Middle Aged; Pain; Pyrazinamide; Random Allocation; Time Factors; Tuberculosis, Pulmonary; Uric Acid | 1979 |
Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Aspirin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Middle Aged; Prednisolone; Pyrazinamide; Radiography; Rifampin; Treatment Outcome; Tuberculosis, Meningeal; Young Adult | 2014 |
19 other study(ies) available for aspirin and pyrazinamide
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
The pharmacology of the hypouricemic effect of benzbromarone.
Topics: Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Drug Interactions; Glomerular Filtration Rate; Kidney Tubules; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1977 |
The pharmacology of hypouricemic effect of benzbromarone.
Topics: Adult; Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Creatinine; Female; Gout; Humans; Male; Middle Aged; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1975 |
Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy.
Topics: Ascorbic Acid; Aspirin; Female; Humans; Kidney; Kidney Calculi; Male; Models, Biological; Pyrazinamide; Uric Acid | 1976 |
Renal tubular hypouricemia: evidence for defect of both secretion and reabsorption.
Topics: Aged; Aspirin; Creatinine; Furosemide; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Middle Aged; Probenecid; Pyrazinamide; Uric Acid | 1990 |
Pharmacologic effects of nicotinic acid on human purine metabolism.
Topics: Adult; Aspirin; Creatinine; Erythrocytes; Female; Gout; Humans; Iopanoic Acid; Kidney Tubules; Male; Middle Aged; Niacinamide; Nicotinic Acids; Organophosphorus Compounds; Pentosephosphates; Pentosyltransferases; Phosphoric Acids; Purines; Pyrazinamide; Pyridines; Sulfinpyrazone; Uric Acid | 1974 |
Evidence for a postsecretory reabsorptive site for uric acid in man.
Topics: Absorption; Adult; Aspirin; Female; Humans; Kidney Tubules; Male; Middle Aged; Probenecid; Pyrazinamide; Sulfinpyrazone; Uric Acid | 1973 |
Evidence for a post-secretory reabsorptive site for uric acid in man.
Topics: Aspirin; Biological Transport; Fasting; Humans; Kidney Tubules; Probenecid; Pyrazinamide; Sulfinpyrazone; Time Factors; Uric Acid | 1974 |
[Kinetics of the appearance in the urine of para-aminohippuric acid (PAH) and of 2-14C uric acid in man. Effects of benziodarone, acetylsalicylic acid and pyrazinamide].
Topics: Aminohippuric Acids; Aspirin; Benzofurans; Carbon Isotopes; Humans; Inulin; Kinetics; Male; Potassium Isotopes; Pyrazinamide; Time Factors; Uric Acid; Vasodilator Agents | 1968 |
INHIBITION OF PYRAZINAMIDE HYPERURICEMIA BY SMALL DOSES OF ACETYLSALICYLIC ACID.
Topics: Aspirin; Blood Chemical Analysis; Drug Therapy; Humans; Hyperuricemia; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Uric Acid | 1964 |
Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Aspirin; Disease Models, Animal; Drug Synergism; Female; Ibuprofen; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Tuberculosis | 2007 |